DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
DURAPATITE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DURAPATITE
×
Maximum Phase:
4
First Approval:
None
UNII:
91D9GV0Z28
Molecule Type:
Small molecule
Molecular Formula:
HCa5O13P3
Molecular Weight:
502.31
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
COLESEVELAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
COLESEVELAM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CASCARA SAGRADA
4
Small molecule
Approved
Unknown
Unknown
Constipation
Laxative
CASCARA SAGRADA
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROMESTRIENE
4
Small molecule
Approved
Unknown
Unknown
Hypospadias
Unknown
PROMESTRIENE
×
Maximum Phase:
4
First Approval:
None
UNII:
GXM4PER6WZ
Molecule Type:
Small molecule
Molecular Formula:
C22H32O2
Molecular Weight:
328.5
AlogP:
5.35
PSA:
18.46
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TRITOQUALINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity
Unknown
TRITOQUALINE
×
Maximum Phase:
4
First Approval:
None
UNII:
F4MW5166YH
Molecule Type:
Small molecule
Molecular Formula:
C26H32N2O8
Molecular Weight:
500.55
AlogP:
3.64
PSA:
110.94
HBD:
1.0
HBA:
#RotB:
8.0
Source:
OUABAIN
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
OUABAIN
×
Maximum Phase:
4
First Approval:
None
UNII:
5ACL011P69
Molecule Type:
Small molecule
Molecular Formula:
C29H44O12
Molecular Weight:
584.66
AlogP:
-1.51
PSA:
206.6
HBD:
8.0
HBA:
#RotB:
4.0
Source:
TULOBUTEROL
4
Small molecule
Approved
Unknown
Unknown
Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
TULOBUTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
591I9SU0F7
Molecule Type:
Small molecule
Molecular Formula:
C12H18ClNO
Molecular Weight:
227.74
AlogP:
2.76
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ALCURONIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Muscarinic acetylcholine receptor M2 positive allosteric modulator
ALCURONIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
S8U3J5W06N
Molecule Type:
Small molecule
Molecular Formula:
C44H50N4O2+2
Molecular Weight:
666.91
AlogP:
5.48
PSA:
46.94
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PHENETURIDE
4
Small molecule
Approved
Unknown
Unknown
Epilepsy
Unknown
PHENETURIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
878CEJ4HGX
Molecule Type:
Small molecule
Molecular Formula:
C11H14N2O2
Molecular Weight:
206.25
AlogP:
1.38
PSA:
72.19
HBD:
2.0
HBA:
#RotB:
3.0
Source:
GLUCOSAMINE
4
Small molecule
Approved
Unknown
Unknown
Obesity; Breast Neoplasms; Irritable Bowel Syndrome; Osteoarthritis; Osteoarthritis, Knee; Rheumatic Diseases
Supplement
GLUCOSAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
N08U5BOQ1K
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO5
Molecular Weight:
179.17
AlogP:
-3.25
PSA:
116.17
HBD:
5.0
HBA:
#RotB:
1.0
Source:
DEANOL ACEGLUMATE
4
Small molecule
Approved
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
DEANOL ACEGLUMATE
×
Maximum Phase:
4
First Approval:
None
UNII:
2PP737Z523
Molecule Type:
Small molecule
Molecular Formula:
C11H22N2O6
Molecular Weight:
278.3
AlogP:
-0.56
PSA:
103.7
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TECHNETIUM TC-99M PYROPHOSPHATE KIT
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M PYROPHOSPHATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THIMEROSAL
4
Small molecule
Approved
Unknown
Unknown
Hepatitis B, Chronic
Antimicrobial preservative, used in vaccines
THIMEROSAL
×
Maximum Phase:
4
First Approval:
None
UNII:
2225PI3MOV
Molecule Type:
Small molecule
Molecular Formula:
C9H9HgNaO2S
Molecular Weight:
404.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
INDORAMIN
4
Small molecule
Approved
Unknown
Unknown
Hypertension
Unknown
INDORAMIN
×
Maximum Phase:
4
First Approval:
None
UNII:
0Z802HMY7H
Molecule Type:
Small molecule
Molecular Formula:
C22H25N3O
Molecular Weight:
347.46
AlogP:
3.6
PSA:
48.13
HBD:
2.0
HBA:
#RotB:
5.0
Source:
METRIZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
METRIZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
CM1N99QR1M
Molecule Type:
Small molecule
Molecular Formula:
C12H11I3N2O4
Molecular Weight:
627.94
AlogP:
3.14
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
3.0
Source:
METHYLATROPINE NITRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
METHYLATROPINE NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Q48D9J47K2
Molecule Type:
Small molecule
Molecular Formula:
C18H26N2O6
Molecular Weight:
366.41
AlogP:
2.08
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MERBROMIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MERBROMIN
×
Maximum Phase:
4
First Approval:
None
UNII:
M0T18YH28D
Molecule Type:
Small molecule
Molecular Formula:
C20H8Br2HgNa2O6
Molecular Weight:
750.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BENZALKONIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Cell membrane disrupting agent
BENZALKONIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
7N6JUD5X6Y
Molecule Type:
Small molecule
Molecular Formula:
C22H40N+
Molecular Weight:
318.57
AlogP:
6.57
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
14.0
Source:
LIMAPROST
4
Small molecule
Approved
Unknown
Unknown
Spinal Cord Diseases
Unknown
LIMAPROST
×
Maximum Phase:
4
First Approval:
None
UNII:
L02U804092
Molecule Type:
Small molecule
Molecular Formula:
C22H36O5
Molecular Weight:
380.53
AlogP:
3.89
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
13.0
Source:
XENON XE 133
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
XENON XE 133
×
Maximum Phase:
4
First Approval:
None
UNII:
X3P9A5HNYF
Molecule Type:
Small molecule
Molecular Formula:
Xe
Molecular Weight:
132.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BLONANSERIN
4
Small molecule
Approved
Unknown
Unknown
Schizophrenia
Dopamine D2 receptor antagonist
BLONANSERIN
×
Maximum Phase:
4
First Approval:
None
UNII:
AQ316B4F8C
Molecule Type:
Small molecule
Molecular Formula:
C23H30FN3
Molecular Weight:
367.51
AlogP:
4.69
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
HUPERZINE A
4
Small molecule
Approved
Unknown
Unknown
Cocaine-Related Disorders; Substance-Related Disorders; Alzheimer Disease; Brain Injuries
Unknown
HUPERZINE A
×
Maximum Phase:
4
First Approval:
None
UNII:
0111871I23
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O
Molecular Weight:
242.32
AlogP:
2.0
PSA:
58.88
HBD:
2.0
HBA:
#RotB:
0.0
Source:
CHLORQUINALDOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CHLORQUINALDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
D6VHC87LLS
Molecule Type:
Small molecule
Molecular Formula:
C10H7Cl2NO
Molecular Weight:
228.08
AlogP:
3.56
PSA:
33.12
HBD:
1.0
HBA:
#RotB:
0.0
Source:
BENPERIDOL
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
Dopamine D2 receptor antagonist
BENPERIDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
97O6X78C53
Molecule Type:
Small molecule
Molecular Formula:
C22H24FN3O2
Molecular Weight:
381.45
AlogP:
4.18
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
THONZONIUM BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
THONZONIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
JI2B19CR0R
Molecule Type:
Small molecule
Molecular Formula:
C32H55BrN4O
Molecular Weight:
591.72
AlogP:
8.05
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
22.0
Source:
LICARBAZEPINE
4
Small molecule
Approved
Unknown
Unknown
Epilepsy; Bipolar Disorder
Unknown
LICARBAZEPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
XFX1A5KJ3V
Molecule Type:
Small molecule
Molecular Formula:
C15H14N2O2
Molecular Weight:
254.29
AlogP:
2.49
PSA:
66.56
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DIACETYLMORPHINE
4
Small molecule
Unknown
Unknown
Unknown
Heroin Dependence; Opioid-Related Disorders
Mu opioid receptor agonist
DIACETYLMORPHINE
×
Maximum Phase:
4
First Approval:
None
UNII:
70D95007SX
Molecule Type:
Small molecule
Molecular Formula:
C21H23NO5
Molecular Weight:
369.42
AlogP:
1.99
PSA:
65.07
HBD:
0.0
HBA:
#RotB:
2.0
Source:
MIKAMYCIN
4
Small molecule
Approved
Unknown
Unknown
Tonsillitis; Bacterial Infections
Unknown
MIKAMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
9OQ0EAU5T3
Molecule Type:
Small molecule
Molecular Formula:
C73H89N11O17
Molecular Weight:
1392.57
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
UREA, C-14
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
UREA, C-14
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLATROPINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
METHYLATROPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
80719I460H
Molecule Type:
Small molecule
Molecular Formula:
C18H26NO3+
Molecular Weight:
304.41
AlogP:
2.08
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CADEXOMER IODINE
4
Small molecule
Approved
Unknown
Unknown
Skin Ulcer
Unknown
CADEXOMER IODINE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CINOXATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CINOXATE
×
Maximum Phase:
4
First Approval:
None
UNII:
5437O7N5BH
Molecule Type:
Small molecule
Molecular Formula:
C14H18O4
Molecular Weight:
250.29
AlogP:
2.29
PSA:
44.76
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PIRETANIDE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
PIRETANIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
DQ6KK6GV93
Molecule Type:
Small molecule
Molecular Formula:
C17H18N2O5S
Molecular Weight:
362.41
AlogP:
2.42
PSA:
109.93
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TROLAMINE
4
Small molecule
Approved
Unknown
Unknown
Skin Ulcer
Unknown
TROLAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
9O3K93S3TK
Molecule Type:
Small molecule
Molecular Formula:
C6H15NO3
Molecular Weight:
149.19
AlogP:
-1.73
PSA:
63.93
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ARTEMISININ
4
Small molecule
Approved
Unknown
Unknown
Severe Acute Respiratory Syndrome; Schizophrenia; Malaria
Unknown
ARTEMISININ
×
Maximum Phase:
4
First Approval:
None
UNII:
9RMU91N5K2
Molecule Type:
Small molecule
Molecular Formula:
C15H22O5
Molecular Weight:
282.34
AlogP:
2.39
PSA:
53.99
HBD:
0.0
HBA:
#RotB:
0.0
Source:
1
2
…
171
172
173
174
175
176
177
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA